Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07516509) titled 'Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance' on April 1.
Study Type: Observational
Primary Sponsor: AdventHealth Translational Research Institute
Condition:
Insulin Resistance
Intervention:
Other: VO2 Max
Other: DEXA
Other: Peripheral Microvascular Reactivity
Other: Skeletal Muscle Insulin Sensitivity
Other: Non-Oxidative Glucose Disposal
Recruitment Status: Not recruiting
Date of First Enrollment: June 2026
Target Sample Size: 36
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07516509
Publish...